Literature DB >> 19141833

Improvement in detection of enterotoxigenic Escherichia coli in patients with travelers' diarrhea by increasing the number of E. coli colonies tested.

Thushara Galbadage1, Zhi-Dong Jiang, Herbert L DuPont.   

Abstract

No cause of one-third of travelers' diarrhea (TD) cases can be detected despite microbiologic assessment. We propose that these pathogen-negative TD cases include undetected enterotoxigenic Escherichia coli (ETEC). As a standard in diagnostic microbiology, samples of five E. coli colonies were tested to detect ETEC from stool cultures. We compared the sensitivities and the number of ETEC detected by 20 colonies with those of 5, 10, and 15 colonies. The percent detection of ETEC with five E. coli colonies was significantly different from that using 20 E. coli colonies. Of the 116 subjects studied, the number positive for ETEC for 5, 10, 15 and 20 colonies tested were 22 (19.0%), 37 (31.9%), 45 (38.8%) and 46 (39.7%), respectively. Based on our results, we recommend the testing of at least 10 E. coli colonies for optimum detection of ETEC in patients with TD.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19141833

Source DB:  PubMed          Journal:  Am J Trop Med Hyg        ISSN: 0002-9637            Impact factor:   2.345


  8 in total

1.  Microbiologic methods utilized in the MAL-ED cohort study.

Authors:  Eric Houpt; Jean Gratz; Margaret Kosek; Anita K M Zaidi; Shahida Qureshi; Gagandeep Kang; Sudhir Babji; Carl Mason; Ladaporn Bodhidatta; Amidou Samie; Pascal Bessong; Leah Barrett; Aldo Lima; Alexandre Havt; Rashidul Haque; Dinesh Mondal; Mami Taniuchi; Suzanne Stroup; Monica McGrath; Dennis Lang
Journal:  Clin Infect Dis       Date:  2014-11-01       Impact factor: 9.079

2.  Development of a multiplex polymerase chain reaction assay for diarrheagenic Escherichia coli and Shigella spp. and its evaluation on colonies, culture broths, and stool.

Authors:  Mami Taniuchi; Carol C Walters; Jean Gratz; Athanasia Maro; Happiness Kumburu; Oralak Serichantalergs; Orntipa Sethabutr; Ladaporn Bodhidatta; Gibson Kibiki; Denise M Toney; Lynette Berkeley; James P Nataro; Eric R Houpt
Journal:  Diagn Microbiol Infect Dis       Date:  2012-04-25       Impact factor: 2.803

Review 3.  Recent advances in understanding enteric pathogenic Escherichia coli.

Authors:  Matthew A Croxen; Robyn J Law; Roland Scholz; Kristie M Keeney; Marta Wlodarska; B Brett Finlay
Journal:  Clin Microbiol Rev       Date:  2013-10       Impact factor: 26.132

4.  The Bacteroides fragilis toxin gene is prevalent in the colon mucosa of colorectal cancer patients.

Authors:  Annemarie Boleij; Elizabeth M Hechenbleikner; Andrew C Goodwin; Ruchi Badani; Ellen M Stein; Mark G Lazarev; Brandon Ellis; Karen C Carroll; Emilia Albesiano; Elizabeth C Wick; Elizabeth A Platz; Drew M Pardoll; Cynthia L Sears
Journal:  Clin Infect Dis       Date:  2014-10-09       Impact factor: 9.079

5.  Microbial etiology of travelers' diarrhea in Mexico, Guatemala, and India: importance of enterotoxigenic Bacteroides fragilis and Arcobacter species.

Authors:  Zhi-Dong Jiang; Herbert L Dupont; Eric L Brown; Ranjan K Nandy; Thandavaryan Ramamurthy; Anuradha Sinha; Santanu Ghosh; Sucharita Guin; Kaur Gurleen; Savio Rodrigues; Jacklyn J Chen; Robin McKenzie; Robert Steffen
Journal:  J Clin Microbiol       Date:  2010-01-27       Impact factor: 5.948

6.  Visualization-assisted binning of metagenome assemblies reveals potential new pathogenic profiles in idiopathic travelers' diarrhea.

Authors:  Qiyun Zhu; Christopher L Dupont; Marcus B Jones; Kevin M Pham; Zhi-Dong Jiang; Herbert L DuPont; Sarah K Highlander
Journal:  Microbiome       Date:  2018-11-08       Impact factor: 14.650

Review 7.  Considerations for using ETEC and Shigella disease burden estimates to guide vaccine development strategy.

Authors:  Divya Hosangadi; Peter G Smith; Birgitte K Giersing
Journal:  Vaccine       Date:  2017-10-12       Impact factor: 3.641

Review 8.  Toxin-mediated effects on the innate mucosal defenses: implications for enteric vaccines.

Authors:  Gregory M Glenn; David H Francis; E Michael Danielsen
Journal:  Infect Immun       Date:  2009-09-08       Impact factor: 3.441

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.